919 related articles for article (PubMed ID: 18254066)
1. Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection.
Hollier LM; Wendel GD
Cochrane Database Syst Rev; 2008 Jan; (1):CD004946. PubMed ID: 18254066
[TBL] [Abstract][Full Text] [Related]
2. Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients.
Le Cleach L; Trinquart L; Do G; Maruani A; Lebrun-Vignes B; Ravaud P; Chosidow O
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009036. PubMed ID: 25086573
[TBL] [Abstract][Full Text] [Related]
3. Valacyclovir prophylaxis to prevent recurrent herpes at delivery: a randomized clinical trial.
Sheffield JS; Hill JB; Hollier LM; Laibl VR; Roberts SW; Sanchez PJ; Wendel GD
Obstet Gynecol; 2006 Jul; 108(1):141-7. PubMed ID: 16816068
[TBL] [Abstract][Full Text] [Related]
4. Valacyclovir therapy to reduce recurrent genital herpes in pregnant women.
Andrews WW; Kimberlin DF; Whitley R; Cliver S; Ramsey PS; Deeter R
Am J Obstet Gynecol; 2006 Mar; 194(3):774-81. PubMed ID: 16522412
[TBL] [Abstract][Full Text] [Related]
5. Prevention of perinatal herpes: prophylactic antiviral therapy?
Scott LL
Clin Obstet Gynecol; 1999 Mar; 42(1):134-48; quiz 174-5. PubMed ID: 10073307
[TBL] [Abstract][Full Text] [Related]
6. Vertical transmission of genital herpes: prevention and treatment options.
Jones CA
Drugs; 2009; 69(4):421-34. PubMed ID: 19323586
[TBL] [Abstract][Full Text] [Related]
7. Interventions for men and women with their first episode of genital herpes.
Heslop R; Roberts H; Flower D; Jordan V
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010684. PubMed ID: 27575957
[TBL] [Abstract][Full Text] [Related]
8. Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer.
Glenny AM; Fernandez Mauleffinch LM; Pavitt S; Walsh T
Cochrane Database Syst Rev; 2009 Jan; (1):CD006706. PubMed ID: 19160295
[TBL] [Abstract][Full Text] [Related]
9. Guidance on management of asymptomatic neonates born to women with active genital herpes lesions.
Kimberlin DW; Baley J; ;
Pediatrics; 2013 Feb; 131(2):e635-46. PubMed ID: 23359576
[TBL] [Abstract][Full Text] [Related]
10. Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: a systematic review.
Sheffield JS; Hollier LM; Hill JB; Stuart GS; Wendel GD
Obstet Gynecol; 2003 Dec; 102(6):1396-403. PubMed ID: 14662233
[TBL] [Abstract][Full Text] [Related]
11. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial.
Scott LL; Hollier LM; McIntire D; Sanchez PJ; Jackson GL; Wendel GD
Infect Dis Obstet Gynecol; 2001; 9(2):75-80. PubMed ID: 11495557
[TBL] [Abstract][Full Text] [Related]
12. [Not Available].
Sénat MV; Anselem O; Picone O; Renesme L; Sananès N; Vauloup-Fellous C; Sellier Y; Laplace JP; Sentilhes L
Gynecol Obstet Fertil Senol; 2017 Dec; 45(12):705-714. PubMed ID: 29132768
[TBL] [Abstract][Full Text] [Related]
13. Acyclovir prophylaxis in late pregnancy to prevent neonatal herpes: a cost-effectiveness analysis.
Randolph AG; Hartshorn RM; Washington AE
Obstet Gynecol; 1996 Oct; 88(4 Pt 1):603-10. PubMed ID: 8841227
[TBL] [Abstract][Full Text] [Related]
14. Does frequency of genital herpes recurrences predict risk of transmission? Further analysis of the valacyclovir transmission study.
Kim HN; Wald A; Harris J; Almekinder J; Heitman C; Corey L
Sex Transm Dis; 2008 Feb; 35(2):124-8. PubMed ID: 17921912
[TBL] [Abstract][Full Text] [Related]
15. A randomised placebo controlled trial of suppressive acyclovir in late pregnancy in women with recurrent genital herpes infection.
Brocklehurst P; Kinghorn G; Carney O; Helsen K; Ross E; Ellis E; Shen R; Cowan F; Mindel A
Br J Obstet Gynaecol; 1998 Mar; 105(3):275-80. PubMed ID: 9532986
[TBL] [Abstract][Full Text] [Related]
16. [Management of pregnant women with recurrent herpes. Guidelines for clinical practice from the French College of Gynecologists, Obstetricians (CNGOF)].
Anselem O
Gynecol Obstet Fertil Senol; 2017 Dec; 45(12):677-690. PubMed ID: 29132770
[TBL] [Abstract][Full Text] [Related]
17. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.
Gupta R; Wald A; Krantz E; Selke S; Warren T; Vargas-Cortes M; Miller G; Corey L
J Infect Dis; 2004 Oct; 190(8):1374-81. PubMed ID: 15378428
[TBL] [Abstract][Full Text] [Related]
18. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
Fife KH; Warren TJ; Justus SE; Heitman CK;
Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
[TBL] [Abstract][Full Text] [Related]
19. Reducing the risk of transmitting genital herpes: advances in understanding and therapy.
Leone P
Curr Med Res Opin; 2005 Oct; 21(10):1577-82. PubMed ID: 16238897
[TBL] [Abstract][Full Text] [Related]
20. Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent Recurrences: A Randomized Clinical Trial.
Wald A; Timmler B; Magaret A; Warren T; Tyring S; Johnston C; Fife K; Selke S; Huang ML; Stobernack HP; Zimmermann H; Corey L; Birkmann A; Ruebsamen-Schaeff H
JAMA; 2016 Dec; 316(23):2495-2503. PubMed ID: 27997653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
